NCT00782210 - 12 / 48 Week Pivotal PFT vs PBO in COPD I | Biotech Hunter

Enrollment

625

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Olodaterol (BI1744)

Comparison of low and high doses on efficacy and safety in COPD patients

DRUG

Olodaterol (BI1744)

Comparison of low and high doses on efficacy and safety in COPD patients

DRUG

placebo

Olodaterol (BI1744) placebo inhaled orally once daily from the Respimat inhaler

Trial Locations (54)

Unknown

1222.11.1122 Boehringer Ingelheim Investigational Site, Jasper

1222.11.1116 Boehringer Ingelheim Investigational Site, Berkeley

1222.11.1121 Boehringer Ingelheim Investigational Site, Los Angeles

1222.11.1111 Boehringer Ingelheim Investigational Site, Fort Collins

1222.11.1117 Boehringer Ingelheim Investigational Site, Stamford

1222.11.1110 Boehringer Ingelheim Investigational Site, DeLand

1222.11.1106 Boehringer Ingelheim Investigational Site, Coeur d'Alene

1222.11.1108 Boehringer Ingelheim Investigational Site, Evansville

1222.11.1109 Boehringer Ingelheim Investigational Site, Bowling Green

1222.11.1113 Boehringer Ingelheim Investigational Site, St Louis

1222.11.1115 Boehringer Ingelheim Investigational Site, Larchmont

1222.11.1120 Boehringer Ingelheim Investigational Site, Toledo

1222.11.1105 Boehringer Ingelheim Investigational Site, Oklahoma City

1222.11.1112 Boehringer Ingelheim Investigational Site, Charleston

1222.11.1119 Boehringer Ingelheim Investigational Site, Greer

1222.11.1102 Boehringer Ingelheim Investigational Site, Union

1222.11.1124 Boehringer Ingelheim Investigational Site, Killeen

1222.11.1101 Boehringer Ingelheim Investigational Site, San Antonio

1222.11.1103 Boehringer Ingelheim Investigational Site, Spokane

1222.11.1114 Boehringer Ingelheim Investigational Site, Spokane

1222.11.1123 Boehringer Ingelheim Investigational Site, Tacoma

1222.11.1143 Boehringer Ingelheim Investigational Site, Concord

1222.11.1145 Boehringer Ingelheim Investigational Site, Glebe

1222.11.1144 Boehringer Ingelheim Investigational Site, Westmead

1222.11.1142 Boehringer Ingelheim Investigational Site, Toorak Gardens

1222.11.1141 Boehringer Ingelheim Investigational Site, Woodville

1222.11.1166 Boehringer Ingelheim Investigational Site, Beijing

1222.11.1171 Boehringer Ingelheim Investigational Site, Changsha

1222.11.1170 Boehringer Ingelheim Investigational Site, Chengdu

1222.11.1169 Boehringer Ingelheim Investigational Site, Chongqing

1222.11.1172 Boehringer Ingelheim Investigational Site, Dalian

1222.11.1163 Boehringer Ingelheim Investigational Site, Guangzhou

1222.11.1167 Boehringer Ingelheim Investigational Site, Nanjing

1222.11.1164 Boehringer Ingelheim Investigational Site, Shanghai

1222.11.1165 Boehringer Ingelheim Investigational Site, Shanghai

1222.11.1173 Boehringer Ingelheim Investigational Site, Shenyang

1222.11.1168 Boehringer Ingelheim Investigational Site, Xi'an

1222.11.1151 Boehringer Ingelheim Investigational Site, Berlin

1222.11.1156 Boehringer Ingelheim Investigational Site, Berlin

1222.11.1157 Boehringer Ingelheim Investigational Site, Erfurt

1222.11.1154 Boehringer Ingelheim Investigational Site, Halle

1222.11.1153 Boehringer Ingelheim Investigational Site, Kassel

1222.11.1158 Boehringer Ingelheim Investigational Site, Oschersleben

1222.11.1152 Boehringer Ingelheim Investigational Site, Potsdam

1222.11.1155 Boehringer Ingelheim Investigational Site, Weinheim

1222.11.1138 Boehringer Ingelheim Investigational Site, Hamilton

1222.11.1139 Boehringer Ingelheim Investigational Site, Otahuhu

1222.11.1136 Boehringer Ingelheim Investigational Site, Tauranga

1222.11.1137 Boehringer Ingelheim Investigational Site, Wellington

1222.11.1180 Boehringer Ingelheim Investigational Site, Changhua

1222.11.1181 Boehringer Ingelheim Investigational Site, Chiayi City

1222.11.1179 Boehringer Ingelheim Investigational Site, Taichung

1222.11.1177 Boehringer Ingelheim Investigational Site, Taipei

1222.11.1178 Boehringer Ingelheim Investigational Site, Taipei